slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 70,021-70,050
Pages 3,679
Rows per page 30
Component
70,021-70,050 of 110,355
26
The slide provides a breakdown of financial performance by segment for two consecutive first quarters.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations 1 hit
27
Includes non-GAAP disclosures and constant currency comparisons.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations 1 hit
28
This is a standard financial reconciliation table often found in earnings presentations.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations 1 hit
34
The table provides a detailed breakdown of adjustments including impairments, restructuring costs, and share-based compensation to arrive at non-GAAP Adjusted EBITDA.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations 1 hit
04
The slide uses a split-layout to contrast operational benefits (left) with the specific focus areas of the two business units (right).BenevolentAI | Investor Presentation Deck | 13 slides · BenevolentAI
Pitch deck Investor relations 1 hit
04
Uses a series of four callout boxes to present key statistics regarding food demand and environmental impact.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
Benson Hill | Results Presentation Deck | 23 slidesBenson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
08
The slide uses a hub-and-spoke style layout to show market segments.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
22
Includes two separate reconciliation tables: one for Adjusted EBITDA and one for Free Cash Flow.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations 1 hit
23
Includes a footnote regarding the exclusion of the Fresh business.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations 1 hit
06
Slide includes a map visualization of global instrument installations and customer segment breakdown.Berkeley Lights | Investor Presentation Deck | 15 slides · PhenomeX
Pitch deck Investor relations 1 hit
06
The slide uses a visual comparison between healthy cells (alkaline) and cancer cells (acidic) to demonstrate the selective binding mechanism.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a three-column layout to categorize the platform's versatility.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a Gantt-style visualization to represent clinical trial phases for multiple drug candidates.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
12
Includes a spider plot for target lesion change and a Kaplan-Meier survival curve with a summary table.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
14
The slide uses a decision tree/process flow to map patient cohorts to clinical outcomes and subsequent trial progression.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
15
Includes specific clinical trial data (N=73 and N=26) and detailed breakdown of specific adverse events like constipation, neuropathy, and diarrhea.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
16
Includes detailed footnotes for data sources and medical abbreviations.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
17
The chart is a classic waterfall plot used in oncology to show tumor shrinkage/growth.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
19
The chart highlights two specific cohorts (40% and 44% ORR) within a red box to emphasize efficacy in PD-1 failure populations.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
20
Includes waterfall plot (left) and spider plot (right) for patient response data.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
21
Includes specific clinical trial safety metrics and footnotes regarding data definitions.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
23
The table details specific drug administration schedules (mg/kg) on days 1, 8, 15, and 22 for different cycle lengths.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit
26
The slide uses a grid of metrics to establish the total addressable market and the specific sub-segment (2L+ ROR2+ patients) targeted by the company.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit
27
The chart displays 'Maximum % Change from Baseline in Sum of Target Lesions'.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit
28
Uses a 2x2 grid layout to present key epidemiological and clinical data points.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit
29
The chart is a 'spider plot' or 'swimmer plot' variant showing % change in target lesions over time for two specific patients.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit
30
The slide uses a structured layout to define the patient funnel and clinical need.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit
33
The table details specific drug administration schedules (mg/kg) for different cycle lengths and days.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit
36
The slide uses a combination of a summary table for clinical data and a dot plot for NHP toxicity data.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit